A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
Baker MC, Kavanagh S, Cohen S, Matsumoto AK, Dikranian A, Tesser J, Kivitz A, Alataris K, Genovese MC
Arthritis & Rheumatology · 2023
Key finding
A total of 113 patients (mean age 54 years; 82% female) enrolled, and 101 patients (89.4%) completed week 12.
- Condition
- Rheumatoid Arthritis
- Stimulation
- iVNS
- Evidence tier
- Randomised Controlled Trial
- Participants
- 113
Cite this study
Baker, M. C., Kavanagh, S., Cohen, S., Matsumoto, A. K., Dikranian, A., Tesser, J., Kivitz, A., Alataris, K., & Genovese, M. C. (2023). A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis. Arthritis & Rheumatology, 75(12), 2107-2115. https://doi.org/10.1002/art.42637
Related studies in Rheumatoid Arthritis
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
Tesser et al. · Nature medicine · 2026 · Randomised Controlled Trial
A randomized, double-blind, sham-controlled, clinical trial of auricular vagus nerve stimulation for the treatment of active rheumatoid arthritis: comment on the article by Baker et al
Aranow et al. · Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Randomised Controlled Trial
Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study
Peterson et al. · Bioelectronic medicine · 2024 · Randomised Controlled Trial
Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis—a feasibility study
Parikh et al. · Clinical Rheumatology · 2026 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.